A 51-YEAR old man in Britain has
received a suspended sentence of a
year’s imprisonment for the illegal
importation, sale and supplier of an
unlicensed medicinal product called
‘Triamazon’.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Oct 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Oct 10
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).